However, this reduction is accompanied by a similarly decreased response in circulating IGFBP‐3, resulting in stable levels of free (biologically active) IGF‐1 in the circulation during exercise in humans with obesity. This evidence concerns the gene IGFBP3 and obesity due to melanocortin 4 receptor deficiency.